IDEX Reports Fourth Quarter and Full Year 2023 Results : vim

Fourth Quarter Highlights






Sales of $789 million, down 3% overall and 6% organically



Reported diluted EPS of $1.43, down 16%; adjusted diluted EPS of $1.83, down 9%



Strong operating cash...

Related Keywords

California , United States , Vermont , America , Abhi Khandelwal , Eric Ashleman , Ericd Ashleman , Health Science Technologies , Corporate Office , York Stock Exchange , Muon Group , New York Stock Exchange , Life Sciences , Company Scientific Fluidics Optics , Exchange Commission , Health Science , Material Solutions , Chief Executive Officer , Analytical Instrumentation , Quarter Ended December , Year Ended December , Diluted Earnings , Share Attributable , Net Income , Adjusted Diluted , Metering Technologies , Science Technologies , Diversified Products , Santa Ana , Scientific Fluidics , Executive Officer , President Eric Ashleman , Senior Vice President , Chief Financial Officer Abhi Khandelwal , Private Securities Litigation Reform Act , Hurst Jaws , Consolidated Statements , Common Share , Cash Flows , Segment Financial Information , Iridian Spectral Technologies , Pipeline Renewal Technologies , Consolidated Adjusted , Net Sales , Organic Net , Reported To Adjusted Gross Profit , Gross Margin , Reported To Adjusted Net Income Attributable , Adjusted Net Sales , Operating Activities , Free Cash Flow , Markets ,